Table 2.

Association between stress and distress measures and subsequent biochemically-confirmed abstinence at 6 months.

Model	Covariates	Adjusted odds ratio (Confidence Interval)	P value
Stress Coping (scale 0–10)	Baseline Stress Coping	1.05 (0.92–1.20)	0.47
	3-month Stress Coping	1.05 (0.92–1.21)	0.51
	3-month confirmed abstinence	15.60 (7.75–31.37)	<0.0001
	Treatment Group (IT vs. ST)	1.60 (0.84–3.06)	0.15
	Male (vs. Female)	0.64 (0.32–1.26)	0.19
	Age	1.03 (0.99–1.06)	0.13
	White (vs. non White)	0.70 (0.27–1.85)	0.48
	> High school (vs ≤ high school)	0.95 (0.48–1.89)	0.88
Perceived Stress (PSS-4) (scale 0–16)	Baseline Perceived Stress	1.11 (0.95–1.29)	0.18
	3-month Perceived Stress	0.89 (0.78–1.02)	0.09
	3-month confirmed abstinence	15.84 (7.98–31.43)	<0.0001
	Treatment Group (IT vs. ST)	1.615 (0.84–3.08)	0.15
	Male (vs. Female)	0.62 (0.31–1.22)	0.16
	Age	1.03 (0.99–1.06)	0.12
	>High school (vs ≤ high school)	0.99 (0.49–1.97)	0.97
Distress (NCCN Thermometer) (scale 0–10)	Baseline Distress	1.04 (0.92–1.18)	0.53
	3-month Distress Score	0.97 (0.87–1.08)	0.55
	3-month confirmed abstinence	15.57 (7.85–30.89)	<0.0001
	Treatment Group (IT vs. ST)	1.66 (0.87–3.16)	0.12
	Male (vs. Female)	0.67 (0.34–1.32)	0.24
	Age	1.03 (0.99–1.06)	0.12
	> High school (vs ≤ high school)	0.97 (0.49–1.94)	0.49
Anxiety (GAD-7) (scale 0–21)	Baseline Anxiety	1.07 (0.99–1.15)	0.08
	3-month Anxiety	0.93 (0.87–0.99)	0.03
	3-month confirmed abstinence	14.92 (7.47–29.81)	<0.0001
	Treatment Group (IT vs. ST)	1.74 (0.91–3.34)	0.09
	Male (vs. Female)	0.61 (0.31–1.21)	0.16
	Age	1.03 (0.99–1.06)	0.11
	> High school (vs ≤ high school)	0.99 (0.49–1.99)	0.98

Note. IT, Intensive Treatment group; ST, Standard Treatment group; PSS-4, Perceived Stress Scale; NCCN, National Comprehensive Cancer Network; GAD-7, Generalized Anxiety Disorder scale. Bolded values represent p < .05.